EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies

Sonia Zebachi iD, Julien Tanniou iD, Elisabeth Bakker iD, Sieta T de Vries iD, Rossella Di Bidino iD, Entela Xoxi iD, Anna Glaser iD, Gianluigi Savarese iD, Jan Hillert iD, Peter G M Mol iD, Kelly Plueschke iD, Billy Amzal und 2 weitere

Clinical Pharmacology & Therapeutics · 2025-10 · 118 (4) · 894-905

DOI: 10.1002/cpt.3746 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 02.07.2025. Verfasst von Sonia Zebachi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Quinten Health, Paris, France. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical, Research Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential of real‐world data (RWD), particularly from patient registries, has been increasingly recognized over the last decade by academia, regulators, and health technology assessment (HTA) bodies for its role in assessing a product's effectiveness and supporting regulatory submissions. The selection of an appropriate RWD source is of primary concern, since the success of regulatory processes depends on the quality and relevance of the data. In more recent years, EMA and FDA have released extensive guidance on the use of RWD to produce evidence. Simultaneously, public and private research institutions have proposed structured frameworks developed to guide stakeholders in evaluating and selecting “fit‐for‐purpose” RWD sources. This scoping review provides an overview of these structured frameworks, identifying nine key tools, including the Registry Evaluation and Quality Standards Tool (REQueST) and the Structured Process to Identify Fit‐For‐Purpose Data (SPIFD2). Each framework is briefly described, followed by a comparative analysis of the criteria they assess. These criteria relate to dimensions such as study design, data reliability, data relevance, ethical considerations, and practical factors such as cost and feasibility. Our findings indicate that while these frameworks offer robust tools for ensuring the suitability of RWD sources, each has unique strengths and limitations depending on the specific context of use. By providing a comprehensive understanding of these frameworks, this review aims to assist stakeholders in identifying and/or evaluating and/or selecting the most appropriate RWD sources for generating high‐quality evidence for regulatory and HTA purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology Assessment, BiomedicalResearch DesignHumansRegistriesReproducibility of ResultsInformation Sources

Autor:innen und Institutionen

  • Quinten Health, Paris, France.
  • Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Alta Scuola di Economia e Management dei Sistemi Sanitari (ALTEMS) - Università Cattolica del Sacro Cuore, Rome, Italy.
  • Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • Department of Medicine, Karolinska Institute, Stockholm, Sweden.

ORCID-Profile: Sonia Zebachi, Julien Tanniou, Elisabeth Bakker, Sieta T de Vries, Rossella Di Bidino, Entela Xoxi, Anna Glaser, Gianluigi Savarese, Jan Hillert, Peter G M Mol, Kelly Plueschke, Ghinwa Y Hayek, Jeverson Moreira

Zitieren

APA

Zebachi, S., Tanniou, J., Bakker, E., de Vries, S. T., Di Bidino, R., Xoxi, E., Glaser, A., Savarese, G., Hillert, J., Mol, P. G. M., Plueschke, K., Amzal, B., Hayek, G. Y., & Moreira, J. (2025). Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies. Clinical Pharmacology & Therapeutics, 118(4), 894-905. https://doi.org/10.1002/cpt.3746

Vancouver

Zebachi S, Tanniou J, Bakker E, de Vries ST, Di Bidino R, Xoxi E, et al. Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies. Clinical Pharmacology & Therapeutics. 2025;118(4):894-905. doi:10.1002/cpt.3746

BibTeX
@article{Zebachi2025,
  author = {Zebachi, Sonia and Tanniou, Julien and Bakker, Elisabeth and de Vries, Sieta T and Di Bidino, Rossella and Xoxi, Entela and Glaser, Anna and Savarese, Gianluigi and Hillert, Jan and Mol, Peter G M and Plueschke, Kelly and Amzal, Billy and Hayek, Ghinwa Y and Moreira, Jeverson},
  title = {Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  volume = {118},
  number = {4},
  pages = {894--905},
  doi = {10.1002/cpt.3746}
}
Kostenlos starten →